Cumberland And Gloria Announce Joint R&D Investment

News: US drugmaker Cumberland Pharmaceuticals and Chinese pharmaceutical company Gloria Pharmaceuticals have announced a joint research and development (R&D) investment. Both companies have invested USD1mn in Cumberland Emerging Technologies (CET), which is majority owned by Cumberland and has partnerships with academic research centres to develop promising biopharmaceutical technologies. The investment will be used to speed up the development of CET's pipeline of new product candidates emerging from Vanderbilt University and other regional research centres.

This article is tagged to:
Related sectors of this article: Pharmaceuticals & Healthcare, R&D
Geography: China, United States

Access all of our latest analysis, data and forecasts - request a trial